Nonobese fatty liver disease

Kim, Donghee, Kim, W. Ray·2017·Clinical Gastroenterology and Hepatology
DOI 10.1016/j.cgh.2016.08.028

Cited by (101)

Items 101–101 of 101

  1. Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: a pilot study
    Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Ono, Hirotaka, Kawano, Tadamichi, Yoshida, Yuji, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio et al. · 2022 · JGH Open